Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Nestlé

CTech 24/7

16:00 Unibeam secures $6 million in Seed to expand SIM-based authentication technology
15:13 Check Point's Gil Shwed reflects on stepping down: “I may regret not doing it earlier”
14:54 French New (tech) Wave: The country’s foray into high-tech is cementing Macron’s legacy
14:50 NimBio unveils AI-powered Inflammometer to predict IBD flares before they strike

Nestlé

3 stories about Nestlé

Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24|Adiel Eithan MustakiInvestors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23|Adiel Eithan MustakiThe Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market
07.02.19|Navit ZomerGenerations of Israeli kids grew up eating peanut butter flavored snack Bamba. Now, manufacturer Osem is negotiating a distribution agreement that could make the snack as wildly popular with American kids

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Nestlé

Epitomee surges 200% in two days on FDA approval for weight loss pill

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market